Agenus Stock (NASDAQ:AGEN), Quotes and News Summary

Q: What sector and industry does Agenus (AGEN) operate in?

Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Agenus Stock (NASDAQ: AGEN) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	7.052K / 614.220K
Day Range	- - -
52 Wk Range	4.775 - 42.600
Market Cap	$105.149M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	21
Short Interest	229.66%
Days to Cover	7.43

Recent News

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

Avi Kapoor

Small-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom

The latest Phase 1 trial results of Agenus' botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic CRC showcase promising clinical activity.

Vandana Singh

Gold Moves Higher; Auddia Shares Surge

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.1% on Monday. The Dow traded up 0.04% to 38,919.32 while the NASDAQ rose 0.11% to 16,266.07. The S&P 500 also rose, gaining, 0.07% to 5,208.09.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Agenus Inc

Sector

Health Care

Industry

Biotechnology

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Agenus (AGEN) stock?

You can purchase shares of Agenus (NASDAQ: AGEN) through any online brokerage.

View our list of the best stock brokerages.

Who are Agenus's (AGEN) competitors?

Other companies in Agenus’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS) and FibroGen (NASDAQ:FGEN).

What is the target price for Agenus (AGEN) stock?

The latest price target for Agenus (NASDAQ: AGEN) was reported by B. Riley Securities on Monday, March 18, 2024. The analyst firm set a price target for 5.00 expecting AGEN to fall to within 12 months (a possible -0.40% downside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for Agenus (AGEN)?

The stock price for Agenus (NASDAQ: AGEN) is $5.02 last updated Today at April 19, 2024 at 8:18 AM EDT.

Does Agenus (AGEN) pay a dividend?

There are no upcoming dividends for Agenus.

When is Agenus (NASDAQ:AGEN) reporting earnings?

Agenus’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Agenus (AGEN) going to split?

There is no upcoming split for Agenus.

What sector and industry does Agenus (AGEN) operate in?

Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-